BTI
HRMY icon

Blue Trust Inc’s Harmony Biosciences HRMY Stock Holding History

Blue Trust Inc’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$112 – 2548
2026
Q1 		$112 Sell
4
-25
-86% -$820 ﹤0.01% 2449
2025
Q4 		$1.08K Buy
+29
New +$954 ﹤0.01% 2273
2024
Q4 		– Sell
-282
Closed -$8.51K – 2681
2024
Q3 		$8.51K Buy
282
+185
+191% +$6.5K ﹤0.01% 2247
2024
Q2 		$3.26K Buy
+97
New +$2.92K ﹤0.01% 2319
2024
Q1 		– Sell
-26
Closed -$1K – 2436
2023
Q4 		$1K Sell
26
-193
-88% -$5.39K ﹤0.01% 2331
2023
Q3 		$8K Buy
219
+216
+7,200% +$7.5K ﹤0.01% 1476
2023
Q2 		$0 Buy
+3
New +$104 ﹤0.01% 2249

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blue Trust Inc's HRMY Position: Q2 2026 in Review

Blue Trust Inc sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 4 shares — an estimated $112 sold.

Blue Trust Inc first reported a position in HRMY in Q2 2023 and held it in 7 quarters. The position peaked at $8.51K in Q3 2024. 326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Blue Trust Inc reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Blue Trust Inc sold 4 Harmony Biosciences shares in Q2 2026, an estimated $112.
  • Blue Trust Inc first reported a position in Harmony Biosciences in Q2 2023 and held it in 7 quarters.
  • Blue Trust Inc's Harmony Biosciences position peaked at $8.51K in Q3 2024.
  • 326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.